Democratizing Organ-On-A-Chip Technology
Source: Emulate
Watch this featured session from Boston MPS Day where Luke Dimasi, Senior Director, Product Management, Emulate discusses the evaluation of chimeric antigen receptor (CAR) CAR T-Cell therapy recruitment and efficacy with Organ-on-a-Chip technology. Learn about CAR T-cell therapy as a promising cancer treatment, challenges in CAR T development for solid tumors, why 2D cell models fall short for researchers studying CAR T-cells, the advantages of modeling the holistic CAR T journey with Organ-Chips, and more.
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Emulate
This website uses cookies to ensure you get the best experience on our website. Learn more